Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species

21 May 2003

Abstract excerpt

Receipt of a broad-spectrum cephalosporin is a strong risk factor for isolation of broad-spectrum cephalosporin-resistant Enterobacter species, and yet the risk from other broad-spectrum beta-lactams hydrolyzed by group 1 beta-lactamases has not been well characterized. We compared the risk conferred by broad-spectrum cephalosporins to that conferred by piperacillin-tazobactam, alone or in combination with an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Enterobacteriaceae and Cronobacter Research
Share to Mycobacterium research and diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12760862
DOI: 10.1128/aac.47.6.1882-1886.2003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter SpeciesPMID 12760862Read ↗

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative RodsSemantic proximity Read ↗

Association of OXA-1 and TEM-1 Genes with Antibiotic Resistance to Piperacillin/Tazobactam in ESBL-Producing Pathogens: Insights from a Multi-Center AnalysisSemantic proximity Read ↗

Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.Semantic proximity Read ↗

Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Community HospitalsSemantic proximity Read ↗

Diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections: a nested case-control studySemantic proximity Read ↗

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical CenterSemantic proximity Read ↗

Clinical Outcomes of Third-Generation Cephalosporins, Carbapenems, and Piperacillin-Tazobactam in the Treatment of AmpC- Associated Enterobacterales Species SepsisSemantic proximity Read ↗

Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.Semantic proximity Read ↗

Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospitalSemantic proximity Read ↗

Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacteriaceae in critically ill patients with hospital or ventilator-acquired pneumonia. A propensity score-matched analysisSemantic proximity Read ↗

Mortality associated with third generation cephalosporin-resistance in <i>Enterobacteriaceae</i> infections: a multicentre cohort study in Southern ChinaSemantic proximity Read ↗

Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among <i>Enterobacter</i> sppSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.